Axid AR is first H2 antagonist to provide "complete" heartburn prevention data.
This article was originally published in The Tan Sheet
Executive Summary
AXID AR PACKAGE INSERT INCLUDES "COMPLETE PREVENTION" EFFICACY DATA illustrated by two bar graphs. FDA cleared Whitehall-Robins' Axid AR for OTC marketing on May 9 ("The Tan Sheet" May 13, p. 1). Axid AR is indicated for prevention of heartburn, acid indigestion and sour stomach.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning